Enzo Biochem, Inc.
(NYSE : ENZ)

( )
ENZ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.88%93.921.3%$988.55m
BIIBBiogen Inc.
2.45%229.891.3%$619.18m
AMGNAmgen Inc.
1.22%180.481.3%$474.61m
GILDGilead Sciences, Inc.
2.13%64.140.9%$448.87m
ILMNIllumina, Inc.
1.49%319.203.5%$295.43m
REGNRegeneron Pharmaceuticals, Inc.
2.80%349.992.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
1.18%174.611.9%$236.35m
ALXNAlexion Pharmaceuticals, Inc.
4.30%135.682.0%$176.60m
EXASExact Sciences Corporation
0.27%95.3925.3%$169.11m
AAgilent Technologies, Inc.
1.23%76.721.6%$147.38m
SRPTSarepta Therapeutics, Inc.
1.74%120.2214.7%$129.47m
ONCESpark Therapeutics, Inc.
0.64%111.3811.2%$116.56m
INCYIncyte Corporation
0.57%73.942.5%$97.68m
IONSIonis Pharmaceuticals, Inc.
0.72%73.868.3%$96.82m
BMRNBioMarin Pharmaceutical Inc.
-0.21%85.314.3%$92.88m

Company Profile

Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.